Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels?

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Elevated prostate-specific antigen (PSA) levels can be associated with high-grade prostatic intraepithelial neoplasia (HGPIN), benign prostatic hyperplasia (BPH), or prostate cancer.
• Distinguishing the source of elevated PSA in the presence of HGPIN is crucial for accurate diagnosis and patient management.

Purpose of the Study:

• To investigate the correlation between HGPIN volume, benign prostatic hyperplasia (BPH), and serum PSA levels in radical prostatectomy specimens.
• To determine if HGPIN itself can account for elevated PSA or PSA density.

Main Methods:

• Analysis of 65 radical prostatectomy specimens with minimal prostate cancer and BPH.
• Correlation of serum PSA levels and PSA density with tumor volume, BPH volume, and HGPIN volume.

Main Results:

• PSA showed a significant correlation with gland volume (r=0.64), but not with tumor volume or HGPIN volume.
• PSA density did not correlate with tumor volume or HGPIN volume.
• Extensive HGPIN did not consistently correspond to elevated PSA density, suggesting HGPIN alone does not cause high PSA levels.

Conclusions:

• High-grade prostatic intraepithelial neoplasia does not independently account for elevated serum PSA levels.
• Elevated PSA in patients with HGPIN may be attributed to coexisting benign prostatic hyperplasia or, more likely, undiagnosed prostate cancer.
• Further investigation is warranted to clarify the relationship between HGPIN, BPH, and PSA in clinical settings.